A Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized COVID-19 Subjects
Clinical trial NCT05009732 · TERMINATED
Trial details
- NCT number
- NCT05009732
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2023-02-06
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.